title: Ketorolac, nasal polyposis, and bronchial asthma: a cause for concern.
authors.affiliation: Department of Anesthesia, Stanford University School of Medicine, CA 94305.
authors.forename: G R
authors.initials: GR
authors.lastname: Haddow
authors.forename: E
authors.initials: E
authors.lastname: Riley
authors.forename: R
authors.initials: R
authors.lastname: Isaacs
authors.forename: R
authors.initials: R
authors.lastname: McSharry
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced*; D004338:Drug Combinations; D006801:Humans; D007275:Injections, Intravenous; D020911:Ketorolac Tromethamine; D008297:Male; D009298:Nasal Polyps / Q000601:surgery*; D010149:Postoperative Pain / Q000517:prevention & control*; D014046:Tolmetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014325:Tromethamine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014046:Tolmetin